AeroGrow Reports Second Quarter Results
For the quarter ended September 30, 2019 the Company recorded net revenue of $4.4 million, a decrease of 48% vs. the same period in the prior year.
Read More
Aleafia Health Reports First Profitable Third Quarter
Net income improves to $1.9M, from $11.5M loss Q/Q.
Read More
MediPharm Labs Reports Strong, Profitable 2019 Third Quarter While Investing for Future Global Advantage
Revenue was $43.4 million, a 38% increase over Q2 2019.
Read More
General Cannabis Announces Record Revenues and 2019 Third Quarter Results
General Cannabis Corp. surpassed $1 million in revenue for the sixth consecutive quarter, with a 34% increase in year-to-date revenue in 2019 compared to 2018.
Read More
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
For the quarter ended September 30, 2019, the Company reported a net loss of approximately $20,791,000.
Read More
ScottsMiracle-Gro Announces Strong Fourth Quarter Results; U.S. Consumer and Hawthorne Segments Exceed Expectations
U.S. Consumer segment sales increase 8% for full year, up 4% in Q4.
Read More
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
The third quarter of 2019 was a remarkable period of progress and execution for Zynerba.
Read More
Cara Therapeutics Reports Third Quarter 2019 Financial Results
The company completed several key clinical, financing and licensing objectives that position the Company well during the quarter.
Read More
CV Sciences, Inc. Reports Third Quarter 2019 Financial Results
The company Increased Retail Distribution by Over 800 Stores.
Read More
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Third Quarter Ended September 30, 2019
Epidiolex U.S. year to date net sales of $188.0 million, including Q3 net sales of $86.1 million.
Read MoreGET LISTED
